30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Perry Andrew

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 72% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Perry Andrew's trades of G1 Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-08 2024-07-05
S Sale
77,747 -26.6%
246.54
US$4,574,318 		77,747 -26.6% 246.54 US$4,574,318
2024-05-15 2024-05-13
S Sale
37,589 +11.6%
131.81
US$1,250,770 		37,589 +11.6% 131.81 US$1,250,770
2024-01-08 2024-01-03
S Sale
47,077 +45.2%
253.85
US$979,601 		47,077 +45.2% 253.85 US$979,601
2024-01-08 2024-01-03
S Sale
379 -0.4%
3.12
US$1,182 		379 -0.4% 3.12 US$1,182
2023-07-07 2023-07-05
PlS Planned sale
355 -0.6%
2.45
US$871 		355 -0.6% 2.45 US$871
2023-01-05 2023-01-04
S Sale
820 -3.7%
5.58
US$4,572 		820 -3.7% 5.58 US$4,572